![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Combination Therapy With A Nucleoside Polymerase (RG7128) And Protease (RG7227/ITMN-191) Inhibitor In HCV: Safety, Pharmacokinetics, And Virologic Results From INFORM-1
|
|
|
Reported by Jules Levin
AASLD Nov 3 2009, Boston, MA
EJ Gane, SK Roberts, CA Stedman, PW Angus, B Ritchie, R Elston, D Ipe, PN Morcos, I Najera, T Chu, MM Berrey, WZ Bradford, M Laughlin, NS Shulman, PF Smith
Auckland Clinical Studies, Auckland, New Zealand; The Alfred, Melbourne, Australia: Christchurch Clinical Studies, Christchurch, New Zealand; Austin Hospital, Heidelberg, Australia; Royal Adelaide Hospital, Adelaide, Australia; Roche Palo Alto LLC, Palo Alto, CA; Pharmasset, Inc., Princeton, NJ; Intermune, Inc., Brisbane, CA, USA
![image002.gif](../images/110409/110409-5/image002.gif)
![image004.gif](../images/110409/110409-5/image004.gif)
![image006.gif](../images/110409/110409-5/image006.gif)
![image008.gif](../images/110409/110409-5/image008.gif)
![image010.gif](../images/110409/110409-5/image010.gif)
![image012.gif](../images/110409/110409-5/image012.gif)
![image014.gif](../images/110409/110409-5/image014.gif)
![image016.gif](../images/110409/110409-5/image016.gif)
![image018.gif](../images/110409/110409-5/image018.gif)
![image020.gif](../images/110409/110409-5/image020.gif)
![image022.gif](../images/110409/110409-5/image022.gif)
![image024.gif](../images/110409/110409-5/image024.gif)
![image026.gif](../images/110409/110409-5/image026.gif)
![image028.gif](../images/110409/110409-5/image028.gif)
![image030.gif](../images/110409/110409-5/image030.gif)
from 2 different studies
![image032.gif](../images/110409/110409-5/image032.gif)
![image034.gif](../images/110409/110409-5/image034.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|